NRXS
Q3 2026 EPS Estimate
$-0.32
Sep 17, 2026 · Reports before open
Revenue Estimate
$2M
FY2028E EPS$0.39

Analyst Sentiment

Wall St. Consensus
Buy
1 analyst·Low coverage
75
Score
1 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$8.00
+14.1%
Consensus
$8.00
+14.1%
Bull
$8.00
+14.1%
12-Month Target Range1 analyst
$8.00$8.00$8.00
Current $7.01Consensus
Current Price
$7.01
Upside to Consensus
$0.99

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+112.22%
EPS
FY2028
Rev+58.45%
EPS
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028E
Revenue Avg$10M$21M$33M
Low$9M$20M$32M
High$10M$21M$33M
EBITDA Avg$-10M$-21M$-33M
Low$-10M$-21M$-33M
High$-9M$-20M$-32M
EBIT Avg$-10M$-21M$-33M
Low$-10M$-21M$-33M
High$-9M$-20M$-32M
Net Income Avg$-6M$-545,003.5$4M
Low$-8M$-555,381$3M
High$-5M$-534,626$4M
EPS Avg$-0.68$-0.06$0.39
Low$-0.84$-0.06$0.38
High$-0.52$-0.06$0.40
Analysts (Rev / EPS)2 / 21 / 11 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$3M$4M$4M$5M$6M$6M$7M$8M
Low$3M$3M$4M$5M$5M$6M$7M$7M
High$3M$4M$4M$5M$6M$6M$7M$8M
EBITDA Avg$-3M$-4M$-4M$-5M$-6M$-6M$-7M$-8M
Low$-3M$-4M$-4M$-5M$-6M$-6M$-7M$-8M
High$-3M$-3M$-4M$-5M$-5M$-6M$-7M$-7M
EBIT Avg$-3M$-4M$-4M$-5M$-6M$-6M$-7M$-8M
Low$-3M$-4M$-4M$-5M$-6M$-6M$-7M$-8M
High$-3M$-3M$-4M$-5M$-5M$-6M$-7M$-7M
Net Income Avg$-1M$-711,627$-656,887$-328,443$-437,924$328,443$437,924$766,368
Low$-1M$-763,993$-705,224$-352,612$-470,149$304,275$405,700$709,975
High$-1M$-659,262$-608,550$-304,275$-405,700$352,612$470,149$822,761
EPS Avg$-0.12$-0.07$-0.06$-0.03$-0.04$0.03$0.04$0.07
Low$-0.12$-0.07$-0.06$-0.03$-0.04$0.03$0.04$0.06
High$-0.11$-0.06$-0.06$-0.03$-0.04$0.03$0.04$0.08
Analysts (Rev / EPS)2 / 21 / 11 / 11 / 11 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Dec 22, 2025Craig-Hallum
Neuraxis price target raised to $8 from $7 at Craig-Hallum
Target:$8.00
+136.0%from $3.39
Jun 16, 2025Craig-Hallum
Neuraxis initiated with a Buy at Craig-Hallum
Target:$7.00
+177.8%from $2.52
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.